Genetic diversity and drug resistance of Mycobacterium tuberculosis in Ecuador

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
J ZuritaI Alcocer

Abstract

The genetic diversity of Mycobacterium tuberculosis in Quito, Ecuador is not well known. To investigate mutations related to drug resistance and bacterial genotypes in M. tuberculosis strains in Ecuador. This was a retrospective study of M. tuberculosis isolates from 104 patients. Isolates were phenotypically resistant to rifampicin (RMP) and/or isoniazid (INH). The genotype was determined using 24-locus mycobacterial interspersed repetitive units-variable-number tandem repeats (MIRU-VNTR). Isolates showed mutations in the rpoB and katG genes, and the inhA promoter. In rpoB, we found 13 genetic alterations at codons 511, 513, 514, 515, 516, 526 and 531. Forty-six (44.2%) RMP-resistant isolates belonged to codon 531. In katG, there were nine genetic alterations at codons 296, 312, 314, 315, 322, 324 and 351. Fifty-three (51%) INH-resistant isolates belonged to codon 315. Five mutations not previously described were identified in katG: Thr324Ser, Thr314Ala, Ala312Pro, Trp351Stop and deleted G at 296 codon. The Latin American Mediterranean (LAM) (33.7%) and Ghana (30.8%) lineages presented most of the main mutations observed. This is the first report from Ecuador; it describes five new mutations in katG and indicates that LAM is t...Continue Reading

Citations

Mar 19, 2019·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Daniel Garzon-ChavezJacobus H de Waard
Apr 12, 2020·Scientific Reports·Daniel Garzon-ChavezJacobus H de Waard
Jan 7, 2020·Pathogens and Global Health·M I Cerezo-CortésM I Murcia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.